Last Price | 3.03 | Max Price | 3.53 |
Min Price | 1.20 | 1 Year return | 65.57 |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 31 | 2,019,579 | 0.00 % |
2020 | 30 | 2,170,517 | 0.00 % |
2021 | 34 | 2,404,876 | 0.00 % |
2022 | 28 | 2,645,792 | 0.00 % |
2023 | 0 | 0 | 0.00 % |
No Records Found
No Records Found
No Records Found
The company mostly operates in the health care eq. & services sector. The global health care companies gained around 102 percent over the period 2006-2016. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.
Over the last 12 months, that were loss-making period for the investors in Icad Inc, the stock lost around 21 percent. Over the past 5 years the stock rose a massive 27,06 percent. Icad Inc's revenues between 2011 and 2015 were very fluctuating and moved between 28,28 million dollars and 41,55 million dollars. Icad Inc's net results between 2011 and 2015 were very constant and moved between -37,59 million dollars and -32,45 million dollars.
Over the past 5 years the American company paid out dividends.
At the end of 2015 the health care company's balance sheet equaled 48,64 million dollars. 15,89 million dollars (32,67 percent of the total balance sheet) was financed by debt. Last year the health care company's price/earnings-ratio (PE) was around -11. So the investors valued the stock at -11 times 2015' earnings per share. Based on it's price/earnings-ratio and dividend yield the American stock can be seen as a value stock.
At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 66,19 million dollars. At the end of 2015 around 15,69 million stocks were listed.
All Icad Inc's annual reports can be found here. More information about Icad Inc can be found it's website. .
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
42
|
26
|
28
|
26
|
31
|
30
|
Costs |
74
|
36
|
42
|
35
|
45
|
47
|
Profit |
-32
|
-10
|
-14
|
-9
|
-14
|
-18
|
Margin of profit |
-78.10
|
-38.34
|
-50.75
|
-35.21
|
-43.24
|
-59.29
|
ROI |
-99.08
|
-40.34
|
-99.86
|
-130.72
|
-267.26
|
-57.68
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
33
|
25
|
14
|
7
|
5
|
31
|
Debt |
16
|
14
|
18
|
25
|
37
|
25
|
Total assets |
49
|
39
|
32
|
32
|
42
|
56
|
Solvency |
67.33
|
64.79
|
44.44
|
21.74
|
12.14
|
54.93
|
Cash |
15
|
9
|
9
|
12
|
15
|
27
|
Cashflow |
-2
|
-5
|
-7
|
-4
|
-7
|
-7
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
-0.12
|
-0.40
|
-0.41
|
-0.16
|
-0.19
|
-0.28
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
5.17
|
3.24
|
3.44
|
3.70
|
7.77
|
Eps |
-0.63
|
-0.87
|
-0.54
|
-0.74
|
-0.80
|
Price/earnings-ratio |
-8.21
|
-3.72
|
-6.37
|
-5.00
|
-3.79
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
1.57
|
0.86
|
0.41
|
0.26
|
1.30
|
Market to book |
0.30
|
0.27
|
0.12
|
0.07
|
0.43
|
Cashflow per stock |
-0.34
|
-0.44
|
-0.23
|
-0.37
|
-0.30
|
Stocks |
16
|
17
|
17
|
19
|
24
|
Market Cap |
82.32
|
53.54
|
58.07
|
71.63
|
71.23
|
Date
|
Price
|
---|---|
22 Apr 2025
|
3.03
|
09 Apr 2025
|
1.71
|
08 Apr 2025
|
1.71
|
03 Apr 2025
|
1.95
|
30 Mar 2025
|
2.14
|
27 Mar 2025
|
2.20
|
26 Mar 2025
|
2.27
|
20 Mar 2025
|
2.47
|
15 Mar 2025
|
2.29
|
12 Mar 2025
|
2.21
|
01 Mar 2025
|
2.41
|
25 Feb 2025
|
2.54
|
23 Feb 2025
|
2.70
|
18 Feb 2025
|
3.32
|
13 Feb 2025
|
3.53
|
12 Feb 2025
|
3.47
|
07 Feb 2025
|
3.47
|
05 Feb 2025
|
3.30
|
02 Feb 2025
|
3.20
|
21 Jan 2025
|
1.97
|
17 Jan 2025
|
1.90
|
09 Jan 2025
|
1.96
|
17 Dec 2024
|
1.81
|
10 Dec 2024
|
1.88
|
06 Dec 2024
|
1.68
|
03 Dec 2024
|
1.76
|
29 Nov 2024
|
1.77
|
27 Nov 2024
|
1.73
|
13 Nov 2024
|
2.40
|
08 Nov 2024
|
1.89
|